[1]
M. E. Hale, MD, T. R. Zimmerman, Jr, MD, Y. Ma, MS, and R. Malamut, MD, “Twelve-month, open-label assessment of long-term safety and abuse potential of hydrocodone extended-release formulated with abuse-deterrence technology in patients with chronic pain”, J of Opioid Management, vol. 11, no. 5, pp. 425–434, Sep. 2015.